USAMRU-K develops and tests improved means for predicting, detecting, preventing, and treating infectious disease threats important to the US Military as well as conduct surveillance,
training, research and response activities which are related to emerging infectious diseases threats. Our team partners with US government
agencies to execute the President’s Emergency Plan for AIDS Relief (PEPFAR) and the President’s Malaria Initiative (PMI).
Development of medical products for infectious diseases requires access to study populations in field sites where the disease agents are endemic as well as access to clinical trials centers capable of conducting
high quality and regulated vaccine and therapeutic trials. Specifically, malaria, HIV/AIDS, enteric pathogens, influenza, hemorrhagic fever viruses, and arthropod-borne diseases are among
the most important of the militarily-relevant infectious agents.